Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases. [electronic resource]
Producer: 20190528Description: 494-503 p. digitalISSN:- 1521-0103
- Animals
- Antineoplastic Agents -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- pathology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Humans
- Indoles -- pharmacology
- Lung Neoplasms -- pathology
- Mice
- Mutation
- Oncogenes -- genetics
- Protein Kinase Inhibitors -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Proto-Oncogene Mas
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.